Loading...
Projects / Programmes source: ARIS

Genetska analiza nekaterih tumor supresor genov (Slovene)

Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   

Code Science Field
B007  Biomedical sciences  Medicine (human and vertebrates) 
B200  Biomedical sciences  Cytology, oncology, cancerology 
Keywords
tumor suppressor genes, oncogenes, genetic analysis, hereditary cancer, hereditary colorectal cancer, HNPCC, FAP, von Hippel-Lindau syndrome, multiple endocrine neoplasya, MEN 2, MEN 1, cancerogenesis, Slovenian population
Evaluation (rules)
source: COBISS
Researchers (9)
no. Code Name and surname Research area Role Period No. of publicationsNo. of publications
1.  09275  PhD Damjan Glavač  Chemistry  Researcher  1998 - 2001  565 
2.  02686  PhD Rastko Golouh  Oncology  Researcher  1998 - 2001  364 
3.  13549  Matjaž Koželj  Metabolic and hormonal disorders  Researcher  1998 - 2001  106 
4.  18361  Tomaž Krašovec    Researcher  1998 - 2001 
5.  01546  PhD Igor Križman  Medical sciences  Researcher  1998 - 2001  144 
6.  07187  PhD Andrej Mašera  Oncology  Researcher  1998 - 2001  132 
7.  07228  PhD Zdenka Ovčak  Oncology  Researcher  1998 - 2001  78 
8.  01502  PhD Metka Ravnik-Glavač  Biochemistry and molecular biology  Head  1998 - 2001  268 
9.  18539  Veronika Špacapan    Researcher  1996 - 2001 
Organisations (3)
no. Code Research organisation City Registration number No. of publicationsNo. of publications
1.  0381  University of Ljubljana, Faculty of Medicine  Ljubljana  1627066  48,238 
2.  0302  Institute of Oncology Ljubljana  Ljubljana  5055733000  15,468 
3.  0312  University Medical Centre Ljubljana  Ljubljana  5057272000  77,465 
Abstract
Genes most frequently connected with hereditary predisposition for cancer are tumor suppressor genes. Known genes (MSH2, MLH1, APC, PT53, VHL, RET) connected with hereditary colorectal cancer, von Hippel-Lindau syndrome, multiple endocrine neoplasya have been studied in Slovenian population. In addition mapping of possible new genes connected with defined pathology is under consideration. PCR-Conformational analysis, detection of LOH and linkage analysis have been used. Results of genetic study will represent a basis for population analysis and a contribution to understanding genetic mechanisms of cancer. The detection of mutation in a given family with hereditary cancer syndrome means also the possibility for presymptomatic genetic testing of family members at risk and thus early detection and prevention of the disease.
Views history
Favourite